98 related articles for article (PubMed ID: 29171988)
21. TRIM66 expression in non-small cell lung cancer: A new predictor of prognosis.
Ma Y; Dai HY; Zhang F; Zhao D
Cancer Biomark; 2017 Sep; 20(3):309-315. PubMed ID: 28946563
[TBL] [Abstract][Full Text] [Related]
22. SATB1 Level Correlates with Ki-67 Expression and Is a Positive Prognostic Factor in Non-small Cell Lung Carcinoma.
Glatzel-Plucinska N; Piotrowska A; Grzegrzolka J; Olbromski M; Rzechonek A; Dziegiel P; Podhorska-Okolow M
Anticancer Res; 2018 Feb; 38(2):723-736. PubMed ID: 29374696
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of Alteration/Deficiency in Activation 3 correlates with poor prognosis in non-small cell lung cancer.
Zhang S; Xu L; Tang Z; Wang H; Gu J; Sun B; Zhang W; Niu D; Feng J
Pathol Res Pract; 2019 Jun; 215(6):152408. PubMed ID: 30954347
[TBL] [Abstract][Full Text] [Related]
24. The clinical significance of transforming acidic coiled-coil protein 3 expression in non-small cell lung cancer.
Jiang F; Kuang B; Que Y; Lin Z; Yuan L; Xiao W; Peng R; Zhang X; Zhang X
Oncol Rep; 2016 Jan; 35(1):436-46. PubMed ID: 26531241
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA PVT1 as a novel biomarker for diagnosis and prognosis of non-small cell lung cancer.
Cui D; Yu CH; Liu M; Xia QQ; Zhang YF; Jiang WL
Tumour Biol; 2016 Mar; 37(3):4127-34. PubMed ID: 26490983
[TBL] [Abstract][Full Text] [Related]
26. Down-regulated MicroRNA 148b expression as predictive biomarker and its prognostic significance associated with clinicopathological features in non-small-cell lung cancer patients.
Ghasemkhani N; Shadvar S; Masoudi Y; Talaei AJ; Yahaghi E; Goudarzi PK; Shakiba E
Diagn Pathol; 2015 Sep; 10():164. PubMed ID: 26377406
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of NDRG3 in patients with breast cancer.
Estiar MA; Zare AA; Esmaeili R; Farahmand L; Fazilaty H; Jafari D; Samadi T; Majidzadeh-A K
Future Oncol; 2017 May; 13(11):961-969. PubMed ID: 28326836
[TBL] [Abstract][Full Text] [Related]
28. E2F2 induction in related to cell proliferation and poor prognosis in non-small cell lung carcinoma.
Chen L; Yu JH; Lu ZH; Zhang W
Int J Clin Exp Pathol; 2015; 8(9):10545-54. PubMed ID: 26617764
[TBL] [Abstract][Full Text] [Related]
29. [Correlations of S100A4 and MMP9 expressions to infiltration, metastasis and prognosis of non-small cell lung cancer].
Chen XL; Wang LC; Zhang WG; Chen XY; Sun ZM
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1254-8. PubMed ID: 18676277
[TBL] [Abstract][Full Text] [Related]
30. High TBX2 expression predicts poor prognosis in non-small cell lung cancer.
Zhang Z; Guo Y
Neoplasma; 2014; 61(4):476-80. PubMed ID: 25027744
[TBL] [Abstract][Full Text] [Related]
31. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
Le H; Zeng F; Xu L; Liu X; Huang Y
Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
[TBL] [Abstract][Full Text] [Related]
32. miR-455-3p serves as prognostic factor and regulates the proliferation and migration of non-small cell lung cancer through targeting HOXB5.
Gao X; Zhao H; Diao C; Wang X; Xie Y; Liu Y; Han J; Zhang M
Biochem Biophys Res Commun; 2018 Jan; 495(1):1074-1080. PubMed ID: 29170127
[TBL] [Abstract][Full Text] [Related]
33. Clinical Significance and Tumor-Suppressive Function of miR-516b in Nonsmall Cell Lung Cancer.
Zhu J; Zhang Y; Yang X; Jin L
Cancer Biother Radiopharm; 2017 May; 32(4):115-123. PubMed ID: 28514208
[TBL] [Abstract][Full Text] [Related]
34. Expression of flotillin-2 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Wang ZM
Int J Clin Exp Pathol; 2015; 8(1):601-7. PubMed ID: 25755751
[TBL] [Abstract][Full Text] [Related]
35. Up-Regulation of miR-21 Expression Predicate Advanced Clinicopathological Features and Poor Prognosis in Patients with Non-Small Cell Lung Cancer.
Tian L; Shan W; Zhang Y; Lv X; Li X; Wei C
Pathol Oncol Res; 2016 Jan; 22(1):161-7. PubMed ID: 26453197
[TBL] [Abstract][Full Text] [Related]
36. miRNA-124 down-regulates SOX8 expression and suppresses cell proliferation in non-small cell lung cancer.
Xie C; Han Y; Liu Y; Han L; Liu J
Int J Clin Exp Pathol; 2014; 7(10):6534-42. PubMed ID: 25400731
[TBL] [Abstract][Full Text] [Related]
37. Combined prognostic value of both RelA and IkappaB-alpha expression in human non-small cell lung cancer.
Zhang D; Jin X; Wang F; Wang S; Deng C; Gao Z; Guo C
Ann Surg Oncol; 2007 Dec; 14(12):3581-92. PubMed ID: 17899287
[TBL] [Abstract][Full Text] [Related]
38. Expression and clinical significance of aminopeptidase N/CD13 in non-small cell lung cancer.
Zhang Q; Wang J; Zhang H; Zhao D; Zhang Z; Zhang S
J Cancer Res Ther; 2015; 11(1):223-8. PubMed ID: 25879366
[TBL] [Abstract][Full Text] [Related]
39. Expression of miR-32 in human non-small cell lung cancer and its correlation with tumor progression and patient survival.
Bai Y; Wang YL; Yao WJ; Guo L; Xi HF; Li SY; Zhao BS
Int J Clin Exp Pathol; 2015; 8(1):824-9. PubMed ID: 25755781
[TBL] [Abstract][Full Text] [Related]
40. Hedgehog signaling pathway molecules and ALDH1A1 expression in early-stage non-small cell lung cancer.
Raz G; Allen KE; Kingsley C; Cherni I; Arora S; Watanabe A; Lorenzo CD; Edwards V DK; Sridhar S; Hostetter G; Weiss GJ
Lung Cancer; 2012 May; 76(2):191-6. PubMed ID: 22115706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
